In this European Pharmaceutical Review article, bioprocess experts from Lonza discuss how molecular format and the product lifecycle phase impact the process, risks and outcomes of upstream technology transfer of biologics. This insightful article delves into the intricacies of transferring technology in the biopharmaceutical industry. It highlights the importance of a structured and modular approach to ensure flexibility, consistency, and agility in meeting market needs.
- Expert Insights: Learn about the impact of molecular format and product lifecycle phase on tech transfer.
- Comprehensive Approach: Understand the key activities and challenges in tech transfer, including process validation, risk assessment, and scalability.
- Real-World Examples: Explore case studies and examples that illustrate successful tech transfer strategies and outcomes.